Deborah Yurgelun-Todd, PhD, describes her past and recent research involving natural citicoline. She explains dosage, application, and future potential for this innovative nutrient used to enhance brain function. She also talks about a recent study in the Lancet demonstrating that citicoline had no benefit for ischemic stroke.
Deborah Yurgelun-Todd, PhD, is director of the Cognitive Neuroimaging Laboratory and a USTAR Investigator at the Brain Institute and a professor of psychiatry at the University of Utah Medical School. She held a similar position at McLean Hospital, Harvard Medical School for 12 years before joining the Utah Medical School. Yurgelun-Todd is a recognized expert on the application of neuroimaging methods to assess neurophysiological and neuropsychological changes associated with normal development and neuropsychiatric disorders.